| IRES | Internal ribosome entry site |
| ITAF | IRES trans-acting factor |
| ALS | Amyotrophic lateral sclerosis |
| hnRNP A1 | Heterogeneous nuclear ribonucleoprotein A1 |
| mTOR | Mechanistic target of rapamycin |
| mTORC | Mechanistic target of rapamycin complex |
| CNS | Central nervous system |
| PI3K | Phosphatidylinositol 3-kinase |
| EGFR | Epidermal growth factor receptor |
| PTEN | Phosphatase and tensin homolog |
| AKT/PKB | Protein kinase B |
| SPR | Surface plasmon resonance |
| FDA | Food and drug administration, United States |
| PDX | Patient derived xenograft |
| RNP | Ribonucleoprotein |
| RRM | RNA recognition motif |
| GST | Glutathione S-transferase |
| FITC | Fluorescein isothiocyanate |
| SCID | Severe combined immunodeficient |
| TUNEL | Terminal deoxynucleotidyl transferase dUTP nick end labeling |
| qrt-PCR | Quantitative reverse transcription polymerase chain reaction |